BOMYNTRA

NDC 65219-672 · Fresenius Kabi USA, LLC

Generic nameDenosumab

Dosage formINJECTION

RouteSUBCUTANEOUS

Active ingredient(s)DENOSUMAB

Strength70 mg/mL

Pharmacologic classRANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]

Marketing categoryBLA

Packages

65219-672-01 — 1 SYRINGE, PLASTIC in 1 CARTON (65219-672-01) / 1.7 mL in 1 SYRINGE, PLASTIC

Q5158 — Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg Medicare Part B payment limit (ASP + 6%): $28.82

FDA lists these products with the same active ingredient.

0143-9165 — Denosumab-qbde, 0143-9166 — Denosumab-qbde, 55513-710 — denosumab, 55513-730 — denosumab, 61314-228 — denosumab, 61314-240 — denosumab, 65219-668 — Denosumab, 65219-670 — Denosumab, 69448-021 — denosumab-desu, 69448-022 — denosumab-desu, 70121-2701 — denosumab-mobz, 70121-2702 — denosumab-mobz, 72606-037 — denosumab-bmwo, 72606-038 — denosumab-bmwo, 72606-058 — denosumab-bmwo, 72606-059 — denosumab-bmwo, 83257-029 — Denosumab-kyqq, 83257-030 — Denosumab-kyqq, 83457-012 — denosumab

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.